Livmarli Oral Product
MRX-803
Approved small_molecule active
Quick answer
Livmarli Oral Product for Alagille Syndrome is a Approved program (small_molecule) at Mirum Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Alagille Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- active